Skip to main content

Advertisement

SpringerLink
Log in

Second assessment of NeuroAIDS in Africa

  • Review
  • Published:
Journal of NeuroVirology Aims and scope Submit manuscript

Abstract

In July of 2006, the National Institute of Mental Health (NIMH) Center for Mental Health Research on AIDS (CMHRA) sponsored the second conference on the Assessment of NeuroAIDS in Africa, which was held in Arusha, Tanzania. The conference mission was to address the regional variations in epidemiology of HIV-related neurological disorders as well as the assessment and diagnosis of these disorders. Participants discussed and presented data regarding the relevance and translation of neuroAIDS assessment measures developed in resource intensive settings and the challenges of neuro-assessment in Africa, including the applicability of current tools, higher prevalence of confounding diseases, and the complexity of diverse cultural settings. The conference presentations summarized here highlight the need for further research on neuroAIDS in Africa and methods for assessing HIV-related neurological disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aaron L, Saadoun D, Calatroni I, Launay O, Memain N, Vincent V, Marchal G, Dupont B, Bouchaud O, Valeyre D, Lortholary O (2004). Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect 10: 388–398.

    Article  CAS  PubMed  Google Scholar 

  • Amod F (2006). AIDS associated toxoplasmosis. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Antinori A, Cingolani A, Giancola ML, Forbici F, De Luca A, Perno CF (2003). Clinical implications of HIV-1 drug resistance in the neurological compartment. Scand J Infect Dis Suppl 35(Suppl 106): 41–44.

    Article  CAS  Google Scholar 

  • Belman AL, Diamond G, Dickson D, Horoupian D, Llena J, Lantos G, Rubinstein A (1988). Pediatric acquired immunodeficiency syndrome. Neurologic syndromes. Am J Dis Child 142: 29–35.

    CAS  PubMed  Google Scholar 

  • Boffito M, Pillay D, Wilkins E (2006). Management of advanced HIV disease: resistance, antiretroviral brain penetration and malignancies. Int J Clin Pract 60: 1098–1106.

    Article  CAS  PubMed  Google Scholar 

  • Bonnet F, Bonarek M, Morlat P, Mercie P, Dupon M, Gemain MC, Malvy D, Bernard N, Pellegrin JL, Beylot J (2003). Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study. Clin Infect Dis 36: 1324–1328.

    Article  CAS  PubMed  Google Scholar 

  • Bottieau E, Noe A, Florence E, Colebunders R (2003). Multiple tuberculous brain abscesses in an HIV-infected patient successfully treated with HAART and antituberculous treatment. Infection 31: 118–120.

    Article  CAS  PubMed  Google Scholar 

  • Breen RA, Swaden L, Ballinger J, Lipman MC (2006). Tuberculosis and HIV co-infection: a practical therapeutic approach. Drugs 66: 2299–2308.

    Article  CAS  PubMed  Google Scholar 

  • Calza L, Manfredi R, Chiodo F (2005). Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy. Clin Nutr 24: 5–15.

    Article  CAS  PubMed  Google Scholar 

  • Cashion MF, Banks WA, Bost KL, Kastin AJ (1999). Transmission routes of HIV-1 gp120 from brain to lymphoid tissues. Brain Res 822: 26–33.

    Article  CAS  PubMed  Google Scholar 

  • Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA, Becker JT, Mellors J, McArthur JC (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52: 607–613.

    CAS  PubMed  Google Scholar 

  • Clements JE (2006). The SIV macaque model of HIV CNS disease. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Clements JE, Li M, Gama L, Bullock B, Carruth LM, Mankowski JL, Zink MC (2005). The central nervous system is a viral reservoir in simian immunodeficiency virus—infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy. J NeuroVirol 11: 180–189.

    CAS  PubMed  Google Scholar 

  • Clifford DB (2006). Ethiopian NeuroAIDS assessment. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, Melaku Z, Zewde A, Gessesse N, Wolday D, Messele T, Teshome M, Evans S (2007). Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J NeuroVirol 13: 67–72.

    Article  PubMed  Google Scholar 

  • Coghlan ME, Sommadossi JP, Jhala NC, Many WJ, Saag MS, Johnson VA (2001). Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases. Clin Infect Dis 33: 1914–1921.

    Article  CAS  PubMed  Google Scholar 

  • Cysique LA, Maruff P, Brew BJ (2004). Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J NeuroVirol 10: 350–357.

    Article  PubMed  Google Scholar 

  • Cysique LA, Maruff P, Brew BJ (2006). Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology 66: 1447–1450.

    Article  PubMed  Google Scholar 

  • Dabis F, Ekpini ER (2002). HIV-1/AIDS and maternal and child health in Africa. Lancet 359: 2097–2104.

    Article  PubMed  Google Scholar 

  • Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL (2002). Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 16: 75–83.

    Article  CAS  PubMed  Google Scholar 

  • Eggers C, Hertogs K, Sturenburg HJ, van Lunzen J, Stellbrink HJ (2003). Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration. AIDS 17: 1897–1906.

    Article  PubMed  Google Scholar 

  • Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA (1997). Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol 42: 679–688.

    Article  CAS  PubMed  Google Scholar 

  • Enting RH, Hoetelmans RM, Lange JM, Burger DM, Beijnen JH, Portegies P (1998). Antiretroviral drugs and the central nervous system. AIDS 12: 1941–1955.

    Article  CAS  PubMed  Google Scholar 

  • Epstein LG, Sharer LR, Oleske JM, Connor EM, Goudsmit J, Bagdon L, Robert-Guroff M, Koenigsberger MR (1986). Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 78: 678–687.

    CAS  PubMed  Google Scholar 

  • Evans S (2006). Assessment of NeuroAIDS in Africa: statistical issues and design. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • FDA (2002). d4T and lactic acidosis with neuromuscular weakness: FDA warning. AIDS Treat News 378: 5–6.

    Google Scholar 

  • Ferrando SJ, Rabkin JG, van Gorp W, Lin SH, McElhiney M (2003). Longitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection. J Neuropsychiatry Clin Neurosci 15: 208–214.

    PubMed  Google Scholar 

  • Gabuzda DH, Hirsch MS (1987). Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis. Ann Intern Med 107: 383–391.

    CAS  PubMed  Google Scholar 

  • Hakim J (2006). Epidemiology of HIV in Africa. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Hall C (2006). HIV associated dementia in the HAART era. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Herzmann C, Johnson MA, Youle M (2005). Long-term effect of acetyl-l-carnitine for antiretroviral toxic neuropathy. HIV Clin Trials 6: 344–50.

    Article  PubMed  Google Scholar 

  • Holding P (2006). Pediatric neuroassessment in Kenya: children exposed to multiple risks. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Hosseinipour M (2006). Lactic acidosis and ascending neuromuscular syndrome. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Imhof A, Ledergerber B, Gunthard HF, Haupts S, Weber R (2005). Risk factors for and outcome of hyperlactatemia in HIV-infected persons: is there a need for routine lactate monitoring? Clin Infect Dis 41: 721–728.

    Article  PubMed  Google Scholar 

  • Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, Nakiyingi J, Rutebemberwa A, Morgan D, Weber J, Gilks C, Whitworth J (2002). Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 185: 1244–1250.

    Article  PubMed  Google Scholar 

  • Kaleebu P, Nankya IL, Yirrell DL, Shafer LA, Kyosiimire-Lugemwa J, Lule DB, Morgan D, Beddows S, Weber J, Whitworth JA (2007). Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort. J Acquir Immune Defic Syndr 45: 28–33.

    Article  CAS  PubMed  Google Scholar 

  • Kanki PJ, Hamel DJ, Sankale JL, Hsieh C, Thior I, Barin F, Woodcock SA, Gueye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, I ND, Essex ME, S MB (1999). Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 179: 68–73.

    Article  CAS  PubMed  Google Scholar 

  • Kramer-Hammerle S, Rothenaigner I, Wolff H, Bell JE, Brack-Werner R (2005). Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res 111: 194–213.

    Article  PubMed  Google Scholar 

  • Lalloo U (2006). CNS TB. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Langford TD, Letendre SL, Larrea GJ, Masliah E (2003). Changing patterns in the neuropathogenesis of HIV during the HAART era. Brain Pathol 13: 195–210.

    Article  CAS  PubMed  Google Scholar 

  • Liner KJ, 2nd, Hall CD, Robertson KR (2007). Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. J NeuroVirol 13: 291–304.

    Article  PubMed  Google Scholar 

  • Lobato MN, Caldwell MB, Ng P, Oxtoby MJ (1995). Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. Pediatric Spectrum of Disease Clinical Consortium. J Pediatr 126: 710–715.

    Article  CAS  PubMed  Google Scholar 

  • Marra CM (2006). Neurosyphilis. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER (1997). Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 42: 689–698.

    Article  CAS  PubMed  Google Scholar 

  • Merry C (2006). Antiretroviral rollout in Africa. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Mielke J (2006). Peripheral nerve disease in HIV-infected subjects. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Moore RD, Wong WM, Keruly JC, McArthur JC (2000). Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS 14: 273–278.

    Article  CAS  PubMed  Google Scholar 

  • Morgello S, Estanislao L, Simpson D, Geraci A, DiRocco A, Gerits P, Ryan E, Yakoushina T, Khan S, Mahboob R, Naseer M, Dorfman D, Sharp V (2004). HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol 61: 546–551.

    Article  PubMed  Google Scholar 

  • Moyle GJ, Datta D, Mandalia S, Morlese J, Asboe D, Gazzard BG (2002). Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors. AIDS 16: 1341–1349.

    Article  PubMed  Google Scholar 

  • Nakasujja N (2006). HIV/AIDS and the use of HAART in Uganda. In: Second Assessment of Neuro AIDS in Africa: Arusha, Tanzania.

  • Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W (2002). HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 31: 171–177.

    PubMed  Google Scholar 

  • Newton C (2006). The definition of HIV encephalopathy in children living in Africa. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Osio M, Muscia F, Zampini L, Nascimbene C, Mailland E, Cargnel A, Mariani C (2006). Acetyl-l-carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency virus patients: an open label study. J Peripher Nerv Syst 11: 72–76.

    Article  CAS  PubMed  Google Scholar 

  • Robertson K, Fiscus S, Kapoor C, Robertson W, Schneider G, Shepard R, Howe L, Silva S, Hall C (1998). CSF, plasma viral load and HIV associated dementia. J NeuroVirol 4: 90–94.

    Article  CAS  PubMed  Google Scholar 

  • Robertson KR, Robertson WT, Ford S, Watson D, Fiscus S, Harp AG, Hall CD (2004). Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr 36: 562–566.

    Article  PubMed  Google Scholar 

  • Saavedra-Lozano J, Ramos JT, Sanz F, Navarro ML, de Jose MI, Martin-Fontelos P, Mellado MJ, Leal JA, Rodriguez C, Luque I, Madison SJ, Irlbeck D, Lanier ER, Ramilo O (2006). Salvage therapy with abacavir and other reverse transcriptase inhibitors for human immunodeficiency-associated encephalopathy. Pediatr Infect Dis J 25: 1142–1152.

    Article  PubMed  Google Scholar 

  • Sacktor N (2006). Assessment of HIV dementia in Uganda: results from the Academic Alliance Cohort. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Sacktor N, Nakasujja N, Robertson K, Clifford DB (2007). HIV-associated cognitive impairment in sub-Saharan Africa—the potential effect of clade diversity. Nat Clin Pract Neurol 3: 436–443.

    Article  PubMed  Google Scholar 

  • Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, Ronald A, Katabira E (2006). Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67: 311–314.

    Article  CAS  PubMed  Google Scholar 

  • Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC (2000). Improvement in HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J NeuroVirol 6: 84–88.

    Article  CAS  PubMed  Google Scholar 

  • Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, Epstein L, Kieburtz K (2002). Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 58: 1764–1768.

    CAS  PubMed  Google Scholar 

  • Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, Schifitto G, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Epstein LG, Marder K (2004). Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 63: 2084–2090.

    CAS  PubMed  Google Scholar 

  • Shanbhag MC, Rutstein RM, Zaoutis T, Zhao H, Chao D, Radcliffe J (2005). Neurocognitive functioning in pediatric human immunodeficiency virus infection: effects of combined therapy. Arch Pediatr Adolesc Med 159: 651–656.

    Article  PubMed  Google Scholar 

  • Simpson DM, Kitch D, Evans SR, McArthur JC, Asmuth DM, Cohen B, Goodkin K, Gerschenson M, So Y, Marra CM, Diaz-Arrastia R, Shriver S, Millar L, Clifford DB (2006). HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology 66: 1679–1687.

    Article  CAS  PubMed  Google Scholar 

  • Stankoff B, Calvez V, Suarez S, Bossi P, Rosenblum O, Conquy L, Turell E, Dubard T, Coutellier A, Baril L, Bricaire F, Lacomblez L, Lubetzki C (1999). Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairment. Eur J Neurol 6: 669–675.

    Article  CAS  PubMed  Google Scholar 

  • Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P (2007). Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 45: 174–182.

    Article  PubMed  Google Scholar 

  • Tozzi V, Balestra P, Galgani S, Narciso P, Ferri F, Sebastiani G, D’Amato C, Affricano C, Pigorini F, Pau FM, De Felici A, Benedetto A (1999). Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS 13: 1889–1897.

    Article  CAS  PubMed  Google Scholar 

  • Tozzi V, Balestra P, Galgani S, Narciso P, Sampaolesi A, Antinori A, Giulianelli M, Serraino D, Ippolito G (2001). Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. J Acquir Immune Defic Syndr 28: 19–27.

    CAS  PubMed  Google Scholar 

  • Traore M (2006). Mali and NeuroAIDS. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Van Rie A (2006). Kinshasa, Congo and children with HIV. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

  • Vasan A, Renjifo B, Hertzmark E, Chaplin B, Msamanga G, Essex M, Fawzi W, Hunter D (2006). Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype, Clin Infect Dis 42: 843–852.

    Article  PubMed  Google Scholar 

  • Wynn HE, Brundage RC, Fletcher CV (2002). Clinical implications of CNS penetration of antiretroviral drugs. CNS Drugs 16: 595–609.

    Article  CAS  PubMed  Google Scholar 

  • Zink MC (2006). Impact of minocycline on SIV CNS and PNS disease. In: Second Assessment of NeuroAIDS in Africa: Arusha, Tanzania.

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, 3114 Bioinformatics Building, CB7025, 27599-7025, Chapel Hill, NC, USA

    Kevin Robertson, Colin Hall & Jeff Liner

  2. Center for Mental Health Research on AIDS, National Institutes of Health/National Institute of Mental Health, Bethesda, Maryland, USA

    Kathy Kopnisky

  3. Department of Medicine, University of Zimbabwe Medical School, Avondale, Harare, Zimbabwe

    James Hakim

  4. Pharmacology and Therapeutics, Trinity Centre, S J H, Trinity College Dublin, Dublin, Ireland

    Concepta Merry

  5. Department of Psychiatry, Makerere University Medical School, Kampala, Uganda

    Noeline Nakasujja

  6. Department of Neurology, University of Bamako Medical School, Point G Hospital Bamako, Mali

    Moussa Traore

  7. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    Ned Sacktor

  8. Departments of Neurology and Medicine, Washington University in St. Louis St. Louis, Missouri, USA

    David Clifford & Christina Marra

  9. Neurosciences Department, Institute of Child Health, London, UK

    Charles Newton

  10. Kenya Medical Research Institute, Kilifi, Kenya

    Charles Newton

  11. Department of Epidemiology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA

    Annelies Van Rie

  12. Centre for Geographic Medicine Research, Coast, Kemri, Kenya

    Penny Holding

  13. University of Oxford, UK

    Penny Holding

  14. Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    Janice Clements & Christine Zink

  15. Department of Medicine, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe

    Jens Mielke

  16. Department of Medicine, Division of Infectious Diseases, University of North Carolina-Chapel Hill, University of North Carolina Project, Lilongwe, Malawi

    Mina Hosseinipour

  17. Enhancing Care Initiative KZN, University of KwaZulu-Natal, Durban, KwaZulu Natal, South Africa

    Umesh Lalloo

  18. Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban ACTG-ICTU, Durban, KwaZulu-Natal, South Africa

    Farida Amod

  19. Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA

    Scott Evans

Authors
  1. Kevin Robertson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kathy Kopnisky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. James Hakim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Concepta Merry
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Noeline Nakasujja
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Colin Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Moussa Traore
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ned Sacktor
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. David Clifford
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Charles Newton
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Annelies Van Rie
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Penny Holding
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Janice Clements
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Christine Zink
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Jens Mielke
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Mina Hosseinipour
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Umesh Lalloo
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Farida Amod
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Christina Marra
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Scott Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Jeff Liner
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Assessment of NeuroAIDS in Africa Conference Participants

Corresponding author

Correspondence to Kevin Robertson.

Additional information

This article is based on the Second Assessment of NeuroAIDS in Africa Conference, Arusha, Tanzania July 17–19, 2006.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robertson, K., Kopnisky, K., Hakim, J. et al. Second assessment of NeuroAIDS in Africa. Journal of NeuroVirology 14, 89–101 (2008). https://doi.org/10.1080/13550280701829793

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1080/13550280701829793

Keywords

Search

Navigation